Influenza infection in patients: Comparing quantitative real time RT-PCR and virus isolation  by Chanyasanha, C. et al.
442 16th ICID Abstracts / International Journal of Infectious Diseases 21S (2014) 1–460
Type: Poster Presentation
Final Abstract Number: 64.002
Session: Virology and Viral Infections (Non-HIV) II
Date: Saturday, April 5, 2014
Time: 12:45-14:15
Room: Ballroom
A proﬁle of dengue outbreak in adults of an
eastern state of India
A. Naskar1, M. Ghosh1, S. Mallik1, S. Pal1, B.
Bandyopadhyay1, S. Mukherjee2, B. Saha1,∗
1 School of Tropical Medicine, Kolkata, West Bengal,
India
2 Calcutta Medical Research Institute, Kolkata, India
Background: Outbreaks of DF/DHF have been reported from
various States of India. The 2012 Dengue outbreak in West Bengal
documented 3630 Dengue cases with 7 deaths.
Methods&Materials: BetweenMarch 2012 toNovember 2012,
156 adult patients in two hospitals with Dengue conﬁrmed by NS1
Ag/& IgM ELISA without other co infections/co morbidities were
evaluated clinically and by routine laboratory investigations, chest
X ray and USG abdomen.
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Results: 56.31%weremale, 65% aged less than 30 years and 28%
between 31-50 years. 58% were from urban areas.
100% had myalgia. 15.5% had arthralgia, with 62.5% having both
small and large joint involvement, and 19% involving either small
or large joints.
Rash was seen in 40.7% which was macular in 74% and maculo-
papular in 23%. Rash appeared on day 3 and disappeared by day 7
in 85.7%.
GI complications occurred in 32% with vomiting, diarrhoea and
both in 69.7%, 24% and 6% respectively. 19.4% patients had hae-
morrhagic manifestations with melena, gum bleeding and vaginal
bleeding being most common.
Within 5 days of onset, 94.17% were NS1 Antigen immunoassay
positive. After day 6 of fever 80.58% were IgM ELISA positive. 6
patients were NS1 negative but IgM positive and 14 patients were
NSI positive but IgM ELISA negative.
48.54% patients had platelet count below 1,00,000 with 17.47%
below 50,000,3.88% below 20,000. 4 patients with hemorrhagic
manifestations had platelet count between 1,00,000 to 1,50,000
and 1 patient with hemorrhagic manifestation had platelet count
more than 1,50,000.
Proteinuria with raised creatinine was seen in 0.13%.
Capillary leak was noted in 28%- bilateral pleural effu-
sion(72.4%), right sided pleural effusion (27.6%), ascites (72.4%).
More than 5 folds increase of SGOT,SGPT and both were found
in 15.53%, 11.65% and 11.65%,2-5 folds increase in 31.06%,24.27%
and 20.38% and <2 folds increase in 17.47%,15.53% and 12.62%
One patient died from DIC.
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Conclusion: Urban males were predominantly affected. 100%
had myalgia, 15.5% arthralgia. Rash seen in 40.7%. GI complications
in 32%, kidney involvement in 0.13%, hemorrhagic manifestations
in 19.4%. 48.54% patients had platelet count below 1,00,000. Liver
enzymes were elevated in 45%. Mortality 0.56%.
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Background: The inﬂuenza A virus infection is a highly con-
tagious acute respiratory tract diseaseswhich can be spread easily
andcauses severemorbidity andmortalityworldwide.Ourprevious
study set up the quantitative real time reverse transcription poly-
merase chain reaction (RT-PCR) assay for detecting the inﬂuenza
A virus infection. The objective of this study were to detect the
inﬂuenza A infection from throat swab (TS) specimens by quanti-
tative real time RT-PCR assay and to compare the results with virus
isolation assay.
Methods & Materials: Laboratory methods were designed for
this study. A total of 410 TS specimens of inﬂuenza like symptoms
were randomly collected from sentinel inﬂuenza like symptoms
in patients throughout Thailand during 2008-2010. These speci-
mens were cultured using virus isolation in Madin Darby Canine
Kidney (MDCK) tissue culture and identiﬁed by inﬂuenza A mono-
clonal antibody labeled ﬂuorescence using the immunoﬂuorescent
antibody (IFA) technique. The quantitative real time RT-PCR which
developed from our previous study was performed for diagnosis
and compared with the results from virus isolation.
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Results: Negative results were approximately four times higher
than positive results (334: 76) through virus isolation. The ratio
of males to females in the positive group was 1.2: 1. The highest
positive age groups were 10-19 years (30.8%), followed by 20-
29 years (23.2%), and 30-39 years (22.4%) respectively. Signs and
symptoms most frequently found were sneezing (46.2%) and sore
throats (24.1%).
When comparing both methods, quantitative real time RT-PCR
indicated 85 positive and 325 negative specimens. On the other
hand, using virus isolation, 76 TS specimens were positive and
334were negative. Sensitivity, speciﬁcity, positive predictive value
(PPV), negative predictive vakue (NPV), and accuracy of quantita-
tive real time RT-PCR assay were 100%, 97.3%, 89.4%, 100%, and
97.8% respectively.
Conclusion: In conclusion, quantitative real time RT-PCR can
be used for routine diagnosis as part of inﬂuenza surveillance and
support in future inﬂuenza outbreaks with the advantages of high
sensitivity, high speciﬁcity, safety from the carcinogen reagents,
and less time consuming when compared with the virus isolation
assay
http://dx.doi.org/10.1016/j.ijid.2014.03.1333
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Chronic hepatitis B treatment guidelines and
real-life facts accompanied with six cases
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Background: Recommendations on the treatment of chronic
hepatitis B (CHB) are evolving and are constantly renewed in accor-
dance with the new literature. Guidelines play a major role in
these recommendations. In this study, we aimed to take care of
the dilemma between real-life and guideline recommendations.
Methods & Materials: Primary non-response (PNR) is deﬁned
as less than 1 log10 IU/ml decrease in HBV DNA level from baseline
at 3 months of therapy. Early switch to a more potent drug in PNR
cases is recommended after conﬁrming the patient’s compliance.
Results: A total of 127 patients’ records were reviewed. Five
of them were HBeAg pozitif and 122 of them were HBeAg nega-
tive CHB. PNR was observed in six patients among HBeAg negative
group. In contrast to guideline recommendations, we detected that
lamivudine treatmentwas continued in these patients. Lamivudine
therapy was stopped in the sixth month of therapy in two of them
due to detectable HBVDNA. However, undetectable HBVDNA level
was observed in four of them and lamivudine therapy was contin-
ued again. Lamivudine therapy in these patients is still continued
with the mean duration of 27 months. Baseline characteristics of
PNR patients with and without undetectable HBV DNA at the sixth
month of lamivudine treatment were presented in Table 1.
Conclusion: Although guidelines deﬁned the primary non-
response asless than 1 log10 IU/mldecrease in HBV DNA level from
baseline at 3 months of therapy, this deﬁnition does not work in
Table 1
Baseline characteristics of primary non-responsers with and without undetectable HBV DNA at the sixth month of treatment
Characteristics Case 1 Case 2 Case 3 Case 4 Case 5 Case 6
Gender Female Female Male Male Male Male
Age (years) 31 28 48 39 38 47
Histological activity index 4 4 5 15 7 7
Fibrosis 2 2 2 4 4 2
Baseline HBV DNA (IU/mL) 4944 1.940.000 7.790 40.700 1.960.000 702.000
ALT (U/L) 62 66 60 25 169 58
AST (U/L) 34 33 47 21 64 31
HBV DNA (IU/mL)
At 3rd month
At 6th month 3538 508.000 4760 13300 956.000 523.000
At 12th month 0 0 0 0 19 49.100
At 20th month 0 0 0 0 switched switched
At 30th month (Continues) (continues) 0(continues) 0(continues) - -
At 40th month
